CONFYZA Trademark

Trademark Overview


On Friday, December 3, 2021, a trademark application was filed for CONFYZA with the United States Patent and Trademark Office. The USPTO has given the CONFYZA trademark a serial number of 97155460. The federal status of this trademark filing is REGISTERED as of Tuesday, January 10, 2023. This trademark is owned by Glaxo Group Limited. The CONFYZA trademark is filed in the Pharmaceutical Products category with the following description:

(Based on 44(d) Priority Application) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders(Based on 44(e)) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointes...
confyza

General Information


Serial Number97155460
Word MarkCONFYZA
Filing DateFriday, December 3, 2021
Status700 - REGISTERED
Status DateTuesday, January 10, 2023
Registration Number6947022
Registration DateTuesday, January 10, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements


Goods and Services(Based on 44(d) Priority Application) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders(Based on 44(e)) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, August 11, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 11, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 11, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 11, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 11, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 10, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 10, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 20, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, September 16, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, September 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 13, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 13, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, September 13, 2022SUSPENSION LETTER WRITTEN
Tuesday, September 13, 2022ASSIGNED TO EXAMINER
Tuesday, December 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 7, 2021NEW APPLICATION ENTERED